Nano-X Imaging (NASDAQ:NNOX) Releases Quarterly Earnings Results, Misses Estimates By $0.19 EPS

Nano-X Imaging (NASDAQ:NNOXGet Rating) posted its quarterly earnings data on Thursday. The company reported ($0.41) earnings per share for the quarter, missing the consensus estimate of ($0.22) by ($0.19), Fidelity Earnings reports. During the same period in the prior year, the company posted ($0.27) EPS.

NNOX stock opened at $10.22 on Friday. The company has a current ratio of 1.80, a quick ratio of 1.80 and a debt-to-equity ratio of 0.01. The company’s 50 day moving average is $10.26 and its 200 day moving average is $13.27. The stock has a market cap of $532.26 million, a price-to-earnings ratio of -7.25 and a beta of 2.68. Nano-X Imaging has a 1-year low of $8.23 and a 1-year high of $34.50.

Hedge funds have recently bought and sold shares of the stock. BlackRock Inc. boosted its stake in Nano-X Imaging by 2.8% in the fourth quarter. BlackRock Inc. now owns 608,534 shares of the company’s stock worth $8,847,000 after buying an additional 16,812 shares in the last quarter. Renaissance Technologies LLC boosted its stake in Nano-X Imaging by 245.6% in the first quarter. Renaissance Technologies LLC now owns 568,990 shares of the company’s stock worth $6,168,000 after buying an additional 404,362 shares in the last quarter. Morgan Stanley boosted its stake in Nano-X Imaging by 1.6% in the third quarter. Morgan Stanley now owns 245,700 shares of the company’s stock worth $5,528,000 after buying an additional 3,871 shares in the last quarter. State Street Corp boosted its stake in Nano-X Imaging by 5.3% in the first quarter. State Street Corp now owns 220,110 shares of the company’s stock worth $2,386,000 after buying an additional 10,980 shares in the last quarter. Finally, Swiss National Bank boosted its stake in Nano-X Imaging by 8.9% in the first quarter. Swiss National Bank now owns 79,800 shares of the company’s stock worth $865,000 after buying an additional 6,500 shares in the last quarter. Institutional investors own 13.50% of the company’s stock.

Separately, Zacks Investment Research cut shares of Nano-X Imaging from a “hold” rating to a “sell” rating in a research report on Wednesday, April 6th.

Nano-X Imaging Company Profile (Get Rating)

Nano-X Imaging Ltd., a development-stage company, develops, produces, and commercializes digital X-ray source technology for the medical imaging industry worldwide. Its X-ray source is based on a novel digital MEMs semiconductor cathode. The company also develops a prototype of the Nanox.ARC, a medical imaging system incorporating its novel digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that will allow for the delivery of medical screening as a service.

See Also

Earnings History for Nano-X Imaging (NASDAQ:NNOX)

Receive News & Ratings for Nano-X Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nano-X Imaging and related companies with MarketBeat.com's FREE daily email newsletter.